Advos

Artificial Intelligence (AI) is emerging as a transformative force capable of democratizing access to knowledge, creativity, and economic opportunities, according to Fidji Simo, the new CEO of Applications at OpenAI. Simo's vision positions AI not just as a technological advancement but as a pivotal tool for empowerment acr...

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) has highlighted the increasing importance of platinum in electrical and clean-energy applications, citing its unique properties such as exceptional conductivity, heat resistance, and catalytic efficiency. These characteristics make platinum indispensable across a ra...

Bollinger Innovations, Inc. (NASDAQ: BINI), formerly known as Mullen Automotive Inc., has officially completed its name and ticker change, effective July 28, 2025. This strategic move unifies the company's commercial Class 1, 3, and 4 electric vehicles under a single brand identity, signaling a new chapter in its evolution....

Calidi Biotherapeutics Inc. (NYSE American: CLDI), a clinical-stage biotechnology firm, has announced a 1-for-12 reverse stock split of its common stock, set to take effect on August 5, 2025. This strategic move, approved by shareholders on July 9 and ratified by the board on July 11, aims to optimize market dynamics, broad...

Fifty 1 Labs, Inc. (OTC: FITY), in collaboration with UAV Corp (OTC: UMAV), is set to host a virtual shareholder teleconference on July 28, 2025, at 12:00 PM EST. The event will be streamed live on X (formerly Twitter) and will feature Dr. James Orbinski, a Senior Scientist and Nobel Peace Prize laureate, who accepted the a...

McEwen Inc. (NYSE: MUX) (TSX: MUX) and Canadian Gold Corp. (TSX-V: CGC) have entered into a binding letter of intent for an all-stock acquisition. This strategic move will see McEwen acquiring all outstanding securities of Canadian Gold, with shareholders of the latter receiving 0.0225 McEwen shares per Canadian Gold share....

HealthLynked Corp. (OTCQB: HLYK), a leader in healthcare technology, has unveiled a newly designed Enterprise Healthcare Solutions Website, www.hlykgroup.com, alongside significant upgrades to its national provider directory. This initiative is designed to serve as a comprehensive resource for insurance carriers, pharmaceut...

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company at the forefront of integrating artificial intelligence (AI) with genomic data for oncology drug discovery, has announced the addition of Dr. Lee T. Schalop to its Board of Directors. Dr. Schalop, renowned for his leadership in biotechnology and his e...

Platinum group metals (PGMs), including rhodium, palladium, and platinum, are anticipated to enter a bullish market phase, according to experts at Goehring and Rozencwajg, a South African investment firm specializing in natural resources. This prediction marks a significant shift for PGMs, which have traditionally been over...

Clene Inc. (NASDAQ: CLNN) is positioning itself as a key player in the neurodegenerative disease market, with its lead drug candidate CNM-Au8® for Amyotrophic Lateral Sclerosis (ALS) progressing toward potential FDA accelerated approval by 2026. The ALS market, expected to reach $1.3 billion by 2034, presents a significant ...

GeoVax Labs, Inc. has announced a new research program to evaluate the GEO-MVA vaccine's delivery through Vaxxas' high-density microarray patch (HD-MAP) technology. This study, conducted at the University of Queensland, aims to assess the vaccine's immunogenicity, delivery efficiency, and thermostability when administered v...

Metavesco, Inc. (OTC: MVCO), a publicly traded diversified holding company, has strategically acquired 28 Ethereum (ETH) at an average price of $3,595, marking a significant expansion of its digital asset strategy. While Bitcoin continues to serve as the company's foundational long-term reserve asset, Ethereum is now being ...

Sauce Essentials, a leading premium cannabis brand, is set to participate in the Summer Haze event, a unique gathering aimed at celebrating Southern California's cannabis culture and community. This invite-only event, scheduled for July 31 at a private estate in Orange County, California, is designed to honor the role of bu...

The American Heart Association has expanded its Cardiovascular-Kidney-Metabolic Health Initiative to 15 regions across the United States, targeting the interconnected conditions that contribute to heart disease and stroke. This initiative, supported by leading pharmaceutical companies, aims to enroll 150 healthcare sites, s...

Telvantis Voice Services Inc., a subsidiary of Telvantis Inc., and Adya Inc. have announced a strategic Memorandum of Understanding (MOU) to collaborate on telecom services, cloud technologies, and digital transformation across Canada and international markets. This partnership is set to explore IoT connectivity services, f...

Phylax Global has announced the launch of military-style tactical training courses specifically designed for civilians, aiming to enhance self-defense capabilities, situational awareness, and personal readiness. In an era where safety and security are paramount, these courses offer practical techniques for real-world scenar...

Residents and businesses in Dallas now have access to specialized legal support for IRS and state tax issues with the expansion of J. David Tax Law into the area. The firm specializes in tax debt resolution, audit defense, and penalty relief, leveraging a strategic, evidence-based approach to negotiate with tax authorities ...

BitFrontier Capital Holdings, Inc. (OTC: BFCH) has announced the complete retirement of its outstanding convertible debt, totaling over $2 million, a move that significantly cleans up its balance sheet and sets a new direction under CEO Dr. Jordan P. Balencic. The debt was settled at $0.01 per share, a price that stands at ...

White Stallion Hay has announced its commitment to breeding and selling top-quality Andalusians specifically for dressage, underscoring the breed's elegance, intelligence, and adaptability in the competitive arena. The organization's focus on equine genetics and performance history ensures that each horse not only meets but...

Lexaria Bioscience Corp. has announced promising interim results from its Phase 1b study, GLP-1-H24-4, highlighting the efficacy of DehydraTECH-semaglutide in reducing side effects compared to the widely used Rybelsus®. The study, conducted in Australia, focuses on the safety, tolerability, and efficacy of DehydraTECH (DHT)...